Compare ARK Genomic Revolution ETF (ARKG) vs Best Buy Co Inc (BBY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Best Buy Co Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Best Buy Co Inc trades at $81.49 (market cap $17.45B). The key difference: Best Buy Co Inc pays a 4.64% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | BBY | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $84.00 |
52-Week Low | $23.09 | $55.52 |
Market Cap | — | $17.45B |
Enterprise Value | — | $19.83B |
Dividend Yield | — | 4.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Best Buy (BBY) trades at $82.80, up 3.51% with a bullish technical signal. The stock shows strong profitability with a 39.1% ROE and has beaten earnings estimates for three consecutive quarters. Recent news highlights strategic shifts under new CEO Jason Bonfig toward higher-margin services like retail media and marketplace expansion, alongside new product launches such as RGB LED TVs and Meta VR partnerships.
Outlook remains cautiously optimistic with a consensus price target of $82.18. The attractive 4.6% dividend yield and improving cash flow support income investors, but risks include macroeconomic pressures on consumer electronics spending and leadership transitions. Revenue declines since 2022 require monitoring for stabilization under new growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Best Buy Co Inc
With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Read more on BBY →
